Metagenomi, Inc. Common Stock (MGX) Earnings History
Net Loss5 years of earnings data (2021–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Metagenomi, Inc. Common Stock (MGX) Earnings Overview
As of June 22, 2026, Metagenomi, Inc. Common Stock (MGX) reported trailing twelve-month net income of -$86M, reflecting -12.9% year-over-year growth. The company earned $-2.29 per diluted share over the past four quarters, with a net profit margin of -348.5%.
Looking at the long-term picture, MGX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$21M in fiscal 2021.
Metagenomi, Inc. Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BEAM (-$65M net income, -57.2% margin), CRSP (-$569M net income, -16569.8% margin), EDIT (-$109M net income, -395.0% margin), MGX has room to improve margins relative to the peer group. Compare MGX vs BEAM →
MGX Earnings vs Peers
Earnings metrics vs comparable public companies
MGX Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$88M | -12.6% | -$96M | $-2.36 | -348.5% | -380.9% |
| 2024 | -$78M | -14.4% | -$89M | $-2.09 | -149.3% | -170.0% |
| 2023 | -$68M | -56.6% | -$78M | $-1.82 | -152.5% | -175.4% |
| 2022 | -$44M | -103.3% | -$45M | $-1.16 | -253.4% | -259.5% |
| 2021 | -$21M | - | -$24M | $-3.62 | -8823.9% | -9854.7% |
Download Data
Export MGX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MGX — Frequently Asked Questions
Quick answers to the most common questions about buying MGX stock.
What is MGX earnings per share (EPS)?
MGX trailing twelve-month (TTM) diluted EPS is $-2.29, reflecting -12.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2025 is available in the table on this page.
What is Metagenomi, Inc. Common Stock's net income?
Metagenomi, Inc. Common Stock (MGX) trailing twelve-month net income is $-86M as of 2025. Earnings declined -12.9% year-over-year.
Is MGX profitable?
MGX is not currently profitable on a TTM basis, reporting a net loss of $-86M. Net margin is -348.5%. Investors should monitor for a return to profitability.
What is MGX's earnings growth rate?
MGX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2025.
What are MGX's profit margins?
Metagenomi, Inc. Common Stock net profit margin is -348.5%, operating margin is -380.9%, and gross margin is +78.9%. Below-average margins reflect competitive or cost pressures. Return on Equity is -44.7%.
Is MGX growing earnings?
MGX earnings are declining — EPS fell -12.9% year-over-year. TTM net income dropped to $-86M. This contrasts with the 5-year CAGR of N/A.
What was MGX's best earnings year?
Metagenomi, Inc. Common Stock's highest annual net income on record is $-21M, achieved in fiscal year 2021. Earnings history on this page spans 2021 to 2025 and includes all annual and quarterly figures.
What were MGX's earnings last quarter?
MGX's most recent reported quarter was Q1 2026. Net income was $-23M with diluted EPS of $-0.61. For a full breakdown of all quarters, see the quarterly earnings table on this page.